“Obesity” is an important cause of chronic non-communicable diseases (NCDs) such as diabetes and hypertension. Fatty liver disease, paralysis, cardiovascular disease and cancer threaten the sustainability of Thailand’s universal health insurance system. Currently, more than 20 million Thais are obese, making the country the second largest in Asia. From the health data warehouse of the Ministry of Public Health (HDC), it emerged that obesity, i.e. people with a body mass index equal to or greater than 25 kilograms/square meter, increased to 45.6% in 2020 and to 46.2% in 2021 and 46.6% in 2020. 2022
Research from the British Medical Journal (BMJ) reported that if the incidence of obesity continues to increase, and Thailand has had no significant changes. It will have an economic impact of up to 4.9% of GDP or around 852 billion baht, which will be spent on medical treatment costs. Indirect expenses and loss of economic productivity creating a huge impact on the Thai economy
The problem of Thais being obese and overweight is therefore a serious national problem that must be resolved urgently. All sectors must work together for good health. sustainable economy and quality Thai society This requires public sector cooperation in changing behaviors to reduce the risk of obesity. While most patients still don’t realize that “obesity is a disease that needs to be cured” because in the long run it will have a negative effect on their health. But considering it only an appearance All parties must create knowledge and understanding of the dangers of obesity which can cause more than 200 other diseases. A relationship has been found between BMI and the risk of various diseases, such as those with a BMI greater than 30 kilograms/square meter or more, 50 percent were found to be at risk of developing osteoarthritis. and hypertension, 40% suffered from sleep apnea. Other diseases such as gastroesophageal reflux disease, fatty liver disease, diabetes and ischemic heart disease. including depression. There is also an increased risk of cancer. and have mental health problems
Novo Nordisk Pharma (Thailand) Company Limited is a leading innovative pharmaceutical company committed to creating innovative treatments for obesity. He had the opportunity to welcome Dr..Chonnan Srikaew, Minister of Public Health Together with the interested group, they visited the Novo Nordisk Obesity Campaign booth at the Pharmathon Run 2024 event celebrating the 30th anniversary of the Pharmacy Council at the Ministry of Public Health. Dr. Chonnan listened to the current situation of obesity problem and gave advice by analyzing body composition with In-body machine, I found that weight, muscle mass and the amount of fat is within normal limits and has a rate basal metabolic rate (BMR) comparable to that of a young person Revealing the secrets to taking care of your health through diet control. and practice kicking the ball
Over the 40 years since Novo Nordisk opened its doors in Thailand, the company has been committed to bringing products and innovations that help improve and improve the quality of life of people suffering from obesity, diabetes and other chronic diseases in Thailand, and to provide cooperation and support of government agencies, partners and various network partners to balance health sustainability for Thai people and for the next generation to have sustainable good health.
#Obesity #appearance #disease #threatens #Thais #Economic #loss #billion #baht
